|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Herzfrequenzvariabilitat als Marker Schlagan-fall-assoziierter Infektionen 显示文摘 | Bramer D Hoyer D | 2014 | Das Neurophysiologie-Labor2014，36，1： | 1 |
| 2 | Using a Progressive Paper to Develop Students' Writing Skills 显示文摘 | Van Bramer Bastin L D | 2013 | Journal of Chemical Education2013，90，6： | 1 |
| 3 | Phar-macokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 4 | Study protocol: predictionof stroke associated infections by markers of autonomic control显示文摘 | Bramer D Hoyer H Giinther A etal | 2014 | BMC Neurol2014，14，： | 1 |
| 5 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | S Mallikaarjun D E Salazar S L Bramer | | 0，，： | 1 |
| 6 | Effects of choline on health across the life course: a systematic review 显示文摘 | Leermakers E T Moreira E M Kiefte-de Jong J C Darweesh S K Visser T Voortman T Bautista P K Chowdhury R Gorman D Bramer W M Felix J F Franco O H | 2015 | Nutrition Reviews2015，73，8： | 1 |
| 7 | Study protocol: prediction of stroke associated infections by markers of autonomic control 显示文摘 | Bramer D Hoyer H Gtinther A | 2014 | BMC Neurol2014，13，14： | 1 |
| 8 | Pharmacokinetics, tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | 2004 | J clin Pharmacol2004，44，2： | 1 |
| 9 | Pharrnaeokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in Normal Healthy Volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | | J Clin Pharmaeol0，44，： | 1 |
| 10 | Study protocol: prediction of stroke associated infections by markers of autonomic control 显示文摘 | Bramer D Hoyer H Gunther A | 2014 | BMC Neurol2014，14，： | 1 |
| 11 | Polish emulsion by pressure method显示文摘 | Von Bramer Paul T McGillen William D | | 0，，12： | 1 |
| 12 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 13 | Lack of effect of renal and hepatic impairment on the pharmacokinetics of aripiprazole显示文摘 | BRAMER S L SHOAF S SALAZAR D E | 2003 | Eur Neurosychopharmacol2003，13，4： | 1 |
| 14 | Pharm-acokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 15 | Phar-macokinetics,tolerability and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 16 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员